6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue

Term ID

CHEBI:233273

Synonyms

a 6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue
amino acid carboxyl end amidated-(PEtn)Man-Man-(PEtn)Man-GlcN-PI residue
H7 de-acylated GPI-amino acid carboxyl end residue

Definition

a GPI-anchor amidated amino acid carboxy end residue where the glycosyl structure derives from the H7 GPI-anchor and is de-acylated at position 2 of the inositol ring.

References

PMID:19837036

Ontology

ChEBI ( EBI )

Relationships

is a type of: GPI-anchor amidated amino acid carboxyl end residue(1-)

GPI-anchor amidated amino acid carboxyl end residue(1-) Show first 5 Terms
has_functional_parent: 2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion

2-acyl-6-[6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion Show first 5 Terms
inverse has_functional_parent: 6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl-sn-glycero-3-phospho)-1D-myo-inositol residue

6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl-sn-glycero-3-phospho)-1D-myo-inositol residue Show first 5 Terms

Phenotype

Phenotype resulting from 6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue

Phenotype where environments contain 6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue

Phenotype modified by environments containing 6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue

Phenotype affecting 6-[amino acid carboxyl end amidated-6-phosphoethanolamine-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->6)-2-phosphoethanolamine-alpha-D-mannosyl-(1->4)-alpha-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue

Human Disease Model